scholarly journals A Second Trimester Caesarean Scar Pregnancy

2014 ◽  
Vol 2014 ◽  
pp. 1-2
Author(s):  
Pooja Sikka ◽  
Vanita Suri ◽  
Seema Chopra ◽  
Neelam Aggarwal

Caesarean scar pregnancy, where conceptus is implanted on previous scar, is a rare entity. We present one such case of scar pregnancy presenting to us in the second trimester and was managed with methotrexate and uterine artery embolization, followed by hysterotomy. Uterus could be conserved and hysterectomy could be avoided.

Author(s):  
Angeline Job ◽  
Spandana S.

The incidence of caesarean scar pregnancy range from 1 in 1800 to 1 in 2500 of all pregnancies. It has been estimated that 6.1% of pregnancies in women with at least one previous Caesarean section and a diagnosis of ectopic pregnancy will be Caesarean scar pregnancy (CSP). There is no consensus on the management of CSP. An invasive intervention such as excision of scar ectopic can reduce recurrence but affects patient’s fertility. Conservative management like administration of methotrexate and uterine artery embolization (UAE) is specially important for young women who want to keep their fertility. This is a case report of a 29-year-old woman who presented with persistent heavy bleeding following failed MTP at 12 weeks of gestation. Ultrasonogarphy was suggestive of Caesarean scar pregnancy and MRI of chronic left adnexal ectopic. Laparotomy also was suggestive of Caesarean scar ectopic. She was managed conservatively with UAE followed by Methotrexate. The procedure was performed successfully, and the patient’s fertility was preserved. Follow up consisted of serial bhCG monitoring which gradually returned to normal levels. She conceived four years after UAE and had an uneventful antenatal period and underwent Elective Cesaraen section at 38 weeks. For those patients with CSP who desire future pregnancy, the comprehensive treatment including UAE can be considered in management.


2020 ◽  
Vol 9 (1-2) ◽  
pp. 25-28
Author(s):  
Patricia Perez-Moneo Perez ◽  
Nerea Ruiz Sacedon ◽  
Belen Aparicio Navarro ◽  
Jorge Gomez Valdes ◽  
Reyes Balanza Chancosa

2019 ◽  
Vol 70 (3) ◽  
pp. 307-316 ◽  
Author(s):  
Ali H. Elmokadem ◽  
Rihame M. Abdel-Wahab ◽  
Ahmed A. El-Zayadi ◽  
Mohamed M. Elrakhawy

Introduction The incidence of caesarean scar pregnancy (CSP) and cervical pregnancy (CP) has increased significantly in recent years. The related hemorrhage can be lethal and often needs hysterectomy. This study aims to assess the technical and clinical results of uterine artery embolization (UAE) combined with intra-arterial methotrexate (MTX) infusion for CSP and CP. Methods A retrospective study was conducted for 11 patients (age range from 25–40 years, mean; 31.8 y) with CSP (7/11) and CP (4/11). The diagnosis was confirmed by elevated b-hCG levels (mean 31.245 mIU/mL) with sonography and/or magnetic resonance imaging. They were treated with UAE using particulate embolic material. In all patients, the infusion of MTX (50 mg/m2) was performed before UAE. Follow-up periods after UAE ranged between 6-24 months included weekly sonography and b-hCG level assessment. A literature review was performed using standard online search tools. Results In 10 patients, UAE controlled active vaginal bleeding and reduced post-procedural b-hCG levels significantly by the second week. One patient presented with persistent elevated b-hCG level and vaginal rebleeding. The rebleeding was successfully controlled by second UAE procedure. The ectopic pregnancies were resolved, and the uterus was preserved in all patients. No major complications were detected. Normal menses resumed within 2 months after UAE. Two patients had subsequent natural successful intrauterine pregnancies. Conclusion UAE combined with intra-arterial MTX infusion resulted in resolution of ectopic pregnancies with control of hemorrhage and without hysterectomy in this small group of patients.


Sign in / Sign up

Export Citation Format

Share Document